Xu, P., Zhang, L., & Wu, Q. (2024). Factors influencing Nirmatrelvir/Ritonavir concentration in patients with COVID-19. BMC Infectious Diseases, 24(1), 1. https://doi.org/10.1186/s12879-024-10291-6
Chicago Style (17th ed.) CitationXu, Ping, Lijun Zhang, and Qingguo Wu. "Factors Influencing Nirmatrelvir/Ritonavir Concentration in Patients with COVID-19." BMC Infectious Diseases 24, no. 1 (2024): 1. https://doi.org/10.1186/s12879-024-10291-6.
MLA (9th ed.) CitationXu, Ping, et al. "Factors Influencing Nirmatrelvir/Ritonavir Concentration in Patients with COVID-19." BMC Infectious Diseases, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12879-024-10291-6.
Warning: These citations may not always be 100% accurate.